[{"NetIncomeLoss_1_Q3_USD":-14779000.0,"Liabilities_0_Q3_USD":33467000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":60000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-114000.0,"RevenueFromRelatedParties_3_Q3_USD":12493000.0,"RevenueFromRelatedParties_1_Q3_USD":3028000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"DepreciationAndAmortization_3_Q3_USD":911000.0,"DepreciationAndAmortization_1_Q3_USD":300000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":17684000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":7741000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":3190557.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":5208887.0,"InterestAndOtherIncome_3_Q3_USD":704000.0,"InterestAndOtherIncome_1_Q3_USD":153000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":214213000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":83000.0,"IncomeTaxesPaid_3_Q3_USD":3000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":102769000.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":117411000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3495590.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":144000.0,"CommonStockSharesIssued_0_Q3_shares":19589637.0,"IncreaseDecreaseInDeferredLiabilities_3_Q3_USD":-119000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":23160000.0,"Assets_0_Q3_USD":150397000.0,"ShareBasedCompensation_3_Q3_USD":3616000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":5593764.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":2880000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":84960000.0,"OtherAssetsNoncurrent_0_Q3_USD":2187000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1442000.0,"ConversionOfStockAmountConverted1_3_Q3_USD":114083000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-2493000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":236793.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":1560000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":24651000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":8942000.0,"DeferredFinanceCostsGross_0_Q3_USD":200000.0,"CashAcquiredFromAcquisition_3_Q3_USD":64114000.0,"AccruedProfessionalFeesCurrentAndNoncurrent_0_Q3_USD":1016000.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q3_USD":17371000.0,"PrepaidExpenseCurrent_0_Q3_USD":2416000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-1174000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-1224000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-2676000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":3000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":3428000.0,"CommonStockValue_0_Q3_USD":1000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-14893000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-27660000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-14779000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-27720000.0,"FairValueOfAssetsAcquired_3_Q3_USD":84142000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":1018000.0,"DebtConversionConvertedInstrumentAmount1_3_Q3_USD":2922000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":6849000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":897000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":44985000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":36000.0,"OtherComprehensiveIncomeLossBeforeTax_1_Q3_USD":-114000.0,"OtherComprehensiveIncomeLossBeforeTax_3_Q3_USD":60000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":114083000.0,"OtherAssetsCurrent_0_Q3_USD":55000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"InterestReceivableCurrent_0_Q3_USD":67000.0,"LitigationSettlementExpense_3_Q3_USD":200000.0,"RestrictedCashNoncurrent_0_Q3_USD":4527000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":5700000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":3560000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":4549000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q3_shares":195898.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":83000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":3525000.0,"Goodwill_0_Q3_USD":20739000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-30396000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-14776000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2966000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-28207000.0,"LiabilitiesCurrent_0_Q3_USD":30077000.0,"AccountsPayableCurrent_0_Q3_USD":3838000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":157000.0,"InterestExpense_3_Q3_USD":84000.0,"InterestExpense_1_Q3_USD":50000.0,"NetIncomeLoss_3_Q3_USD":-27720000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2043000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":76000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":367000.0,"PrepaidInsurance_0_Q3_USD":3353000.0,"CommonStockSharesOutstanding_0_Q3_shares":19589637.0,"OperatingLeasePayments_1_Q3_USD":200000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":11.3177,"DevelopmentInProcess_0_Q3_USD":3490000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":826000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":193000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":9291000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":89487000.0,"OperatingLeasePayments_3_Q3_USD":600000.0,"ConversionOfStockAmountConverted1_1_Q3_USD":2922000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":74598000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-97367000.0,"DeferredFinanceCostsNet_0_Q3_USD":100000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5000000.0,"EquityMethodInvestmentOwnershipPercentage_0_Q3_pure":0.25,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"OperatingIncomeLoss_3_Q3_USD":-29842000.0,"OperatingIncomeLoss_1_Q3_USD":-13655000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":23160000.0,"IncomeTaxesReceivable_0_Q3_USD":3400000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":19390000.0,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":16.11,"LiabilitiesAndStockholdersEquity_0_Q3_USD":150397000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":4455000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":3616000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2966000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":6592000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":1000.0,"DeferredRentCreditNoncurrent_0_Q3_USD":102000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":4000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":23077000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":630000.0,"StockholdersEquity_0_Q3_USD":116930000.0,"MarketableSecurities_0_Q3_USD":23160000.0,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_Q3_USD":4124000.0,"ProfitLoss_3_Q3_USD":-27720000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-2.84,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-8.69,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":1738000.0,"OperatingExpenses_1_Q3_USD":16683000.0,"OperatingExpenses_3_Q3_USD":42335000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":41000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":33026000.0,"Ticker":"ACET","CIK":"1720580","name":"ADICET BIO, INC.","OfficialName":"Adicet Bio Inc. Common Stock ","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"311478265.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]